(BOSTON) -- A team of nanobiotechnologists at Harvard's Wyss Institute for Biologically Inspired Engineering and the Dana-Farber Cancer Institute (DFCI) led by Wyss Founding Core Faculty member ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback